Vaccination with ectoparasite proteins involved in midgut function and blood digestion reduces salmon louse infestations

• Published in: Vaccines
• Main Authors: Contreras, Marinela, Karlsen, Marius, Villar, Margarita, Olsen, Rolf Hetlelid, Leknes, Lisa Marie, Furevik, Anette, Yttredal, Karine Lindmo, Tartor, Haitham, Grove, Søren, Alberdi, Pilar, Brudeseth, Bjørn, de la Fuente, José
• Format: Article in Journal/Newspaper
• Language: English
• Published: 2020
• Subjects: Atlantic salmon; Salmo salar
• Online Access: https://hdl.handle.net/11250/2686807; https://doi.org/10.3390/vaccines8010032

Infestation with the salmon louse Lepeophtheirus salmonis (Copepoda, Caligidae) affects Atlantic salmon (Salmo salar L.) production in European aquaculture. Furthermore, high levels of salmon lice in farms significantly increase challenge pressure against wild salmon populations. Currently, available control methods for salmon louse have limitations, and vaccination appears as an attractive, environmentally sound strategy. In this study, we addressed one of the main limitations for vaccine development, the identification of candidate protective antigens. Based on recent advances in tick vaccine research, herein, we targeted the salmon louse midgut function and blood digestion for the identification of candidate target proteins for the control of ectoparasite infestations. The results of this translational approach resulted in the identification and subsequent evaluation of the new candidate protective antigens, putative Toll-like receptor 6 (P30), and potassium chloride, and amino acid transporter (P33). Vaccination with these antigens provided protection in Atlantic salmon by reducing adult female (P33) or chalimus II (P30) sea lice infestations. These results support the development of vaccines for the control of sea lice infestations publishedVersion